nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
British Columbia's biotechnology industry: blending research, business and lifestyle
|
Groote, Joyce |
|
2005 |
10 |
12 |
p. 816-819 4 p. |
artikel |
2 |
Flu pills for a pandemic threat
|
Andrawiss, Mariam |
|
2005 |
10 |
12 |
p. 811- 1 p. |
artikel |
3 |
Genes predict childhood leukemia outcome
|
Foubister, Vida |
|
2005 |
10 |
12 |
p. 812- 1 p. |
artikel |
4 |
Imaging mass spectrometry: fundamentals and applications to drug discovery
|
Rubakhin, Stanislav S. |
|
2005 |
10 |
12 |
p. 823-837 15 p. |
artikel |
5 |
Kinomics: characterizing the therapeutically validated kinase space
|
Vieth, Michal |
|
2005 |
10 |
12 |
p. 839-846 8 p. |
artikel |
6 |
Monitor – biology
|
Lampert, Angelika |
|
2005 |
10 |
12 |
p. 873-874 2 p. |
artikel |
7 |
Monitor – chemistry
|
Edwards, Paul |
|
2005 |
10 |
12 |
p. 872-873 2 p. |
artikel |
8 |
Monitor – in silico
|
Bender, Andreas |
|
2005 |
10 |
12 |
p. 874- 1 p. |
artikel |
9 |
Not all viruses are bad guys: the case for reovirus in cancer therapy
|
Norman, Kara L. |
|
2005 |
10 |
12 |
p. 847-855 9 p. |
artikel |
10 |
Novel second messenger offers drug development opportunities
|
Senior, Kathryn |
|
2005 |
10 |
12 |
p. 810- 1 p. |
artikel |
11 |
Peter Hug on the Roche philosophy to partnering
|
Carney, Stephen |
|
2005 |
10 |
12 |
p. 813-815 3 p. |
artikel |
12 |
Phage therapy: an attractive option for dealing with antibiotic-resistant bacterial infections
|
Sulakvelidze, Alexander |
|
2005 |
10 |
12 |
p. 807-809 3 p. |
artikel |
13 |
The transcriptome's drugable frequenters
|
Dechering, Koen J. |
|
2005 |
10 |
12 |
p. 857-864 8 p. |
artikel |
14 |
Web services in the life sciences
|
Curcin, Vasa |
|
2005 |
10 |
12 |
p. 865-871 7 p. |
artikel |
15 |
Widening bottlenecks in drug discovery Glimpses from Drug Discovery Technology Europe 2005
|
Högberg, Thomas |
|
2005 |
10 |
12 |
p. 820-822 3 p. |
artikel |